Doubova, Svetlana V.
Ferreira-Hermosillo, Aldo
Pérez-Cuevas, Ricardo
Barsoe, Casper
Gryzbowski-Gainza, Erick
Valencia, Juan E.
Funding for this research was provided by:
Medtronic (Without number)
Article History
Received: 16 May 2018
Accepted: 23 July 2018
First Online: 3 August 2018
Ethics approval and consent to participate
: This a secondary data analysis of the baseline characteristics of the group of T1D patients included in the health-economic evaluation study of diabetic treatment at IMSS. The IMSS Research and Ethics Committee approved the study (No. R 2016–785-091). The original study included the review of the clinical records and telephone-interviews after obtaining patients verbal consent.
: Not applicabale. The article does not contain any individual person’s data.
: CB, EGG and JEV are employees of Medtronic PLC. RPC received payment for his participation in this research. SVD and AFH did not receive any fees from Medtronic PLC. SVD received grant from Medtronic that was transferred to the IMSS and spent on the payments for nurses who reviewed patients clinical records. The authors declare their complete independence from Medtronic PLC during the entire research process and are solely responsible for the methods, results, concepts and conclusions contained in this manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.